Table 2 Distribution of the baseline plasma concentrations (ng/mL) of perfluoroalkyl substances (PFASs)

PFOA

0.116

100.00

3.72 (2.14, 6.30)

3.18 (2.27, 4.62)

PFNA

0.220

96.89

1.46 (0.83, 2.30)

1.76 (1.25, 2.34)

PFDA

0.010

99.61

1.04 (0.57, 1.71)

0.91 (0.64, 1.31)

PFUdA

0.009

99.22

0.68 (0.42, 1.03)

0.98 (0.58, 1.60)

PFDoA

0.010

96.80

0.07 (0.04, 0.11)

0.10 (0.06, 0.15)

PFTrDA

0.028

89.71

0.09 (0.02, 0.25)

0.52 (0.36, 0.82)

PFTeDA

0.008

80.97

0.01 (0.01, 0.04)

0.05 (0.03, 0.08)

PFHxS

0.012

99.90

1.18 (0.45, 2.24)

1.59 (0.81, 2.47)

PFHpS

0.030

97.67

0.45 (0.20, 0.80)

0.54 (0.27, 0.94)

PFOS

0.969

99.22

11.14 (6.36, 17.39)

12.64 (8.23, 18.06)

P3MHpS

0.043

92.43

0.86 (0.44, 1.51)

0.87 (0.47, 1.56)

P4MHpS

0.211

91.65

1.11 (0.55, 1.96)

1.20 (0.61, 2.14)

P5MHpS

0.120

96.31

1.79 (0.82, 2.93)

1.85 (0.94, 3.17)

P6MHpS

0.076

84.27

1.61 (0.75, 2.82)

1.77 (0.84, 3.04)

P45DMHxS

0.006

84.08

0.08 (0.02, 0.14)

0.09 (0.04, 0.15)

11CL-PF3OUdS

0.001

99.32

0.11 (0.06, 0.21)

0.11 (0.06, 0.21)

9CL-PF3ONS

0.007

100.00

8.63 (4.49, 15.04)

9.37 (4.85, 15.20)